Home exercise for Neurodegenerative Diseases

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Neurodegenerative Diseases+2 More
Home exercise - Behavioral
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

The primary goal of this study is to address the need for targeted therapeutic interventions for impairments that impact walking in related neurodegenerative diseases.

Eligible Conditions
  • Neurodegenerative Diseases
  • Ataxia
  • Leukodystrophies

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Neurodegenerative Diseases

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: baseline 12 weeks

baseline 12 weeks
Change in NeuroQOL lower extremity

Trial Safety

Safety Progress

1 of 3

Other trials for Neurodegenerative Diseases

Trial Design

1 Treatment Group

Home exercise
1 of 1
Experimental Treatment

30 Total Participants · 1 Treatment Group

Primary Treatment: Home exercise · No Placebo Group · N/A

Home exercise
Behavioral
Experimental Group · 1 Intervention: Home exercise · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Home exercise
2017
Completed Phase 2
~1270

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline 12 weeks

Who is running the clinical trial?

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.Lead Sponsor
81 Previous Clinical Trials
24,409 Total Patients Enrolled
Jennifer Keller, PTPrincipal InvestigatorHugo W. Moser Research Institute at Kennedy Krieger, Inc.

Eligibility Criteria

Age Any Age · All Participants · 9 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
For people with cerebellar ataxia, people with diagnoses of cerebellar damage from stroke, tumor or degeneration will be included.
We will also include patients with other neurodegenerative diseases similar to these disorders as determined by chart review and clinical exam.
You are healthy.
You are ambulatory.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 1st, 2021

Last Reviewed: October 1st, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.